Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
194M
-
Number of holders
-
318
-
Total 13F shares, excl. options
-
144M
-
Shares change
-
-6.79M
-
Total reported value, excl. options
-
$8.96B
-
Value change
-
-$420M
-
Put/Call ratio
-
0.76
-
Number of buys
-
162
-
Number of sells
-
-138
-
Price
-
$62.21
Significant Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q2 2014
384 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share as of Q2 2014.
BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) has 318 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 144M shares
of 194M outstanding shares and own 74.38% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (17.9M shares), SANDS CAPITAL MANAGEMENT, LLC (11.9M shares), FMR LLC (9.22M shares), VANGUARD GROUP INC (8.23M shares), PRIMECAP MANAGEMENT CO/CA/ (8.06M shares), JENNISON ASSOCIATES LLC (5.35M shares), State Street Corp (4.32M shares), BlackRock Institutional Trust Company, N.A. (3.52M shares), WELLS FARGO & COMPANY/MN (2.92M shares), and BlackRock Fund Advisors (2.83M shares).
This table shows the top 318 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.